Lupin wins first FDA ap­proval for gener­ic ver­sion of Boehringer In­gel­heim block­buster Spiri­va

In­di­an drug­mak­er Lupin to­day said it won FDA ap­proval for the first gener­ic ver­sion of Spiri­va, a block­buster COPD drug from Boehringer In­gel­heim.

The gener­ic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER